BTEK.LSE iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)

ETF Healthcare Equity BlackRock Asset Management Ireland - ETF London Exchange
- GBP
No recent price
Total assets
447M
Expense ratio
0.34%
Dividend yield
-
1-year return
+37.29%
Holdings
248
Since
2017

Fund data as reported by the issuer, updated Nov 2, 2026. Total assets are in the fund's base currency.

What does BTEK.LSE invest in?

Tracks Morningstar Gbl Biotechnology NR USD
  • Mostly US stocks (94.0%)
  • Largest sector: Healthcare (100.0%)
  • Largest region: North America (91.3%)
  • Top 3 holdings: 25.6% of the fund

Asset allocation

  • US stocks 94.0%
  • Non-US stocks 4.8%
  • Cash 0.2%

Top holdings

All holdings, sectors and regions

iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) performance

Sharpe ratio 0.00
This year
+28.05%
1 year
+37.29%
3 years
+26.78%
5 years
+8.70%

Volatility 15.7% over 1 year and 17.0% over 3 years. Moderate, similar to a broad stock index.

Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers

BTEK.LSE price

Prices on the chart can differ slightly from the closing prices StockSummer shows.

About iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)

The investment objective of the Fund is to seek to provide investors with a total return, taking into account both capital and income returns, which reflects the return of the NASDAQ Biotechnology Index.

Full fund profile